USSTOCK.TODAY
Regular Market Log in Sign up

Kiniksa Records Record Performance Following ARCALYST Launch and Raises Guidance

Earnings Whispers · ·by G4L

KNSA
KNSA Kiniksa Pharmaceuticals International Plc
$93.54 -1.59%
View chart & analysis →
  1. 1Kiniksa's diluted GAAP earnings per share of $0.56 exceeded the consensus EPS of $0.32.
  2. 2Kiniksa's earnings grew, recording a 75.0% beat against consensus.
  3. 3Management raised the 2026 guidance for ARCALYST.

So what's the key point?

Kiniksa earned $0.56 per share, which was higher than what experts expected. Management also raised the 2026 outlook for ARCALYST.

Source Earnings Whispers · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →